— Know what they know.
Not Investment Advice

GRCU OTC

Global Roundtable Corporation
1W: -99.0% 1M: -99.0% 3M: +0.0% YTD: -99.0% 1Y: -99.0% 3Y: -99.8% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±8129.4%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 49 · $722675 mcap · 5.92B float · 0.0006% daily turnover · Short 65% of daily vol

Cash Flow Trends

Operating Cash Flow
$33K +0.6% ▲
Capital Expenditures
$2 +0.0% ▲
Free Cash Flow
$33K +0.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
$0 -100.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$10K-$521K-$452K$409K-$243K
Depreciation & Amort.$0$0$14K$28K$40K
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$14K$23K-$63K-$533K$236K
Other Non-Cash Items$14K$269K$418K$129K$0
Operating Cash Flow-$4K-$216K-$118K$32K$33K
— Investing Activities —
Capital Expenditures-$517K$0$0-$2$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow-$517K$0$0$0$0
— Financing Activities —
Net Debt Issuance$449K$136K$0-$374K$10K
Stock Repurchased$0$0$0-$578$0
Dividends Paid$0$0$0$0$0
Other Financing$21K-$100K$107K$132K$0
Financing Cash Flow$520K$223K$107K$174K$123K
Net Change in Cash-$780$7K-$11K$207K$0
Cash End of Period$3K$10K-$365$206K$363K
Free Cash Flow-$521K-$216K-$118K$32K$33K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms